Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price on Tuesday jump by nearly 300 percent, with investor optimism fueled by the company’s improved earnings ...
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback